MX337667B - Combinacion simbiotica para mejorar la microbiota intestinal. - Google Patents

Combinacion simbiotica para mejorar la microbiota intestinal.

Info

Publication number
MX337667B
MX337667B MX2009010252A MX2009010252A MX337667B MX 337667 B MX337667 B MX 337667B MX 2009010252 A MX2009010252 A MX 2009010252A MX 2009010252 A MX2009010252 A MX 2009010252A MX 337667 B MX337667 B MX 337667B
Authority
MX
Mexico
Prior art keywords
3galî2l
galî2l
4glc
galî2
6galî2l
Prior art date
Application number
MX2009010252A
Other languages
English (en)
Other versions
MX2009010252A (es
Inventor
Norbert Sprenger
Marie-Claire Fichot
Karl-Josef Huber-Haag
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2009010252A publication Critical patent/MX2009010252A/es
Publication of MX337667B publication Critical patent/MX337667B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a el uso de una cepa probiótica de Lactobacillus rhamnosus y una mezcla oligsacárida la cual comprende 5-70% en peso de por lo menos un oligosacárido N-acetilado que se selecciona del grupo que comprende GalNAca1,3Galß1,4Glc y Galß1,6GalNAcal,3Galß1,4Glc, 20-90% en peso de por lo menos un oligosacárido neutro que se selecciona del grupo que comprende Galß1,6Gal, Galß1,6Galß1,4Glc Galß1,6Galß1,6G1c, Galß1, 3Galß1, 3Glc, Galß1, 3Galß1, 4Glc, Galß1,6Galß1,6Galß1,4Glc, Galß1,6Galß1,3Galß1,4Glc, Galß1,3Galß1,6Galß14Glc y Galß1,3Galß1,3Galß1,4Glc y 5-50% en peso de por lo menos un oligosacárido sialilado que se selecciona del grupo que comprende NeuAca2,3Galß1,4Glc y NeuAca2,6Galß1,4Glc en la elaboración de un medicamento o una composición nutricional terapéutica para reducir el riesgo de desarrollo subsecuente de alergia en lactantes quienes han nacido por cesárea.
MX2009010252A 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal. MX337667B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053661 WO2008116916A1 (en) 2007-03-28 2008-03-27 Synbiotic to improve gut microbiota

Publications (2)

Publication Number Publication Date
MX2009010252A MX2009010252A (es) 2009-10-13
MX337667B true MX337667B (es) 2016-03-14

Family

ID=38051788

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.

Country Status (15)

Country Link
US (4) US20100119488A1 (es)
EP (6) EP1974743A1 (es)
CN (4) CN101646452A (es)
AU (4) AU2008231702B2 (es)
BR (4) BRPI0809356A2 (es)
CA (4) CA2680093A1 (es)
ES (2) ES2434566T3 (es)
MX (4) MX2009009442A (es)
MY (1) MY151137A (es)
PL (2) PL2131859T3 (es)
PT (2) PT2131680E (es)
RU (4) RU2456008C2 (es)
UA (2) UA97662C2 (es)
WO (4) WO2008116916A1 (es)
ZA (3) ZA200907541B (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
CA2644968A1 (en) 2006-03-07 2007-09-13 Nestec S.A. Synbiotic mixture
RU2445361C2 (ru) * 2006-06-13 2012-03-20 Нестек С.А. Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
EP2373182A1 (en) * 2008-12-05 2011-10-12 Nestec S.A. Compositions for use in low-birth weight infants
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
WO2011012655A1 (en) * 2009-07-31 2011-02-03 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
TR201807143T4 (tr) * 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
BR112013017023A2 (pt) * 2010-12-29 2019-09-24 Nestec Sa fibra e probióticos para a redução dos sintomas instestinais relacionados com o estresse
EE05721B1 (et) 2011-02-25 2014-08-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
EP2734049B1 (en) 2011-06-20 2018-05-02 H.J. Heinz Company Brands LLC Probiotic compositions and methods
JP5877902B2 (ja) 2011-08-17 2016-03-08 マイクロバイオーム セラピューティクス，エルエルシー バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
EP2768313B2 (en) * 2011-10-18 2019-01-02 Nestec S.A. Composition for use in the promotion of magnesium absorption and/or magnesium retention
CN116942833A (zh) 2011-12-01 2023-10-27 国立大学法人 东京大学 诱导调节性t细胞的增殖或积累的人源细菌
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
NZ714202A (en) 2013-05-10 2021-07-30 Heinz Co Brands H J Llc Probiotics and methods of use
CN105722514A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物
WO2015071402A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
RU2697650C1 (ru) * 2013-11-15 2019-08-16 Сосьете Де Продюи Нестле С.А. Композиции для профилактики или лечения аллергий у младенцев, рожденных или вскармливаемых матерями несекреторного типа, путем обеспечения фукозилированными олигосахаридами, в частности среди младенцев, подверженных риску или рожденных с помощью кесарева сечения
CN105722409A (zh) * 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗婴儿和幼儿的坏死性小肠结肠炎的组合物
RU2699981C2 (ru) 2014-08-18 2019-09-11 Сосьете Де Продюи Нестле С.А. Пребиотики для снижения риска развития ожирения в дальнейшей жизни
EP3212208B1 (en) * 2014-10-29 2021-03-03 Biogaia AB Use of l. reuteri for prevention or treatment of microbiota dysbiosis in early life
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
ES2879985T3 (es) * 2015-08-04 2021-11-23 Nestle Sa Composiciones nutritivas y fórmulas infantiles que comprenden Bifidobacterium animalis ssp. lactis y, opcionalmente, una mezcla de oligosacáridos para inducir una microbiota intestinal cercana a la de bebés alimentados por lactancia materna
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
US11229659B2 (en) 2016-01-26 2022-01-25 Societe Des Produits Nestle S.A. Compositions with specific oligosaccharides to prevent or treat allergies
EP4268616A3 (en) * 2016-05-31 2023-12-06 Morinaga Milk Industry Co., Ltd. Brain function improving agent
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
WO2018024440A1 (en) 2016-08-04 2018-02-08 Nestec Sa Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
BR112019020443A2 (pt) * 2017-05-05 2020-04-28 Nestle Sa tratamento de cólica em bebês
CN111372477B (zh) * 2017-08-04 2024-05-24 雀巢产品有限公司 在含有gos的培养基中预调理的益生菌及其用途
CN113164532A (zh) * 2018-05-30 2021-07-23 进化生物系统股份有限公司 H5功能性长双歧杆菌婴儿亚种的组合物和使用方法
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
WO2020251249A1 (ko) * 2019-06-11 2020-12-17 주식회사 천랩 영유아의 장내 미생물 불균형도를 탐지하는 방법
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及系统
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
EP4180880A1 (fr) * 2021-11-10 2023-05-17 Montres Breguet S.A. Dispositif d'affichage d'une succession d'indications d'une grandeur temporelle pour une pièce d'horlogerie
EP4536010A1 (en) * 2022-06-10 2025-04-16 DSM IP Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
EP4619504A1 (fr) 2022-11-17 2025-09-24 Institut National de la Recherche pour l'Agriculture, l'Alimentation et l'Environnement Limosilactobacillus mucosae et désordres nécessitant un accroissement du niveau de glp-1
WO2024160209A1 (zh) * 2023-02-01 2024-08-08 北京三元食品股份有限公司 一株母乳来源的鼠李糖乳酪杆菌及应用
CN121450551A (zh) * 2026-01-07 2026-02-03 善恩康生物科技（苏州）有限公司 具有抗炎活性的沙棘源益生菌及其在肠炎治疗中的应用和产品

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
EP0577903B1 (fr) 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
EP0768375B2 (fr) * 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Bactérie lactique
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
EP1646589A1 (en) 2003-06-27 2006-04-19 Bio-Circuit ApS A biogas producing facility with anaerobic hydrolysis
WO2006108824A1 (en) * 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
BRPI0707620A2 (pt) * 2006-02-10 2011-05-10 Nestec Sa mistura de oligossacarÍdeo
CA2644968A1 (en) * 2006-03-07 2007-09-13 Nestec S.A. Synbiotic mixture
RU2445361C2 (ru) * 2006-06-13 2012-03-20 Нестек С.А. Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий

Also Published As

Publication number Publication date
WO2008116907A1 (en) 2008-10-02
AU2008231775A1 (en) 2008-10-02
ES2577434T3 (es) 2016-07-14
PT2131859T (pt) 2016-07-13
EP1974743A1 (en) 2008-10-01
RU2009139669A (ru) 2011-05-10
MX2009010252A (es) 2009-10-13
WO2008116904A1 (en) 2008-10-02
ZA200907541B (en) 2011-04-28
BRPI0809622A2 (pt) 2014-09-16
US20100150874A1 (en) 2010-06-17
CN101652080A (zh) 2010-02-17
RU2521500C2 (ru) 2014-06-27
BRPI0809626A2 (pt) 2014-09-23
CN101646453A (zh) 2010-02-10
MX2009009318A (es) 2009-09-10
US20100119497A1 (en) 2010-05-13
AU2008231763B2 (en) 2013-10-31
BRPI0809356A2 (pt) 2014-09-02
EP2131680B1 (en) 2013-08-14
RU2009139658A (ru) 2011-05-10
EP2129242A1 (en) 2009-12-09
RU2456008C2 (ru) 2012-07-20
AU2008231702B2 (en) 2014-01-16
MY151137A (en) 2014-04-30
US20100086527A1 (en) 2010-04-08
PL2131859T3 (pl) 2016-12-30
EP2489280A2 (en) 2012-08-22
AU2008231763A1 (en) 2008-10-02
CA2679081A1 (en) 2008-10-02
EP2489280A3 (en) 2013-06-26
PT2131680E (pt) 2013-10-28
US20100119488A1 (en) 2010-05-13
RU2009139667A (ru) 2011-05-10
ES2434566T3 (es) 2013-12-16
PL2131680T3 (pl) 2014-01-31
UA97662C2 (ru) 2012-03-12
MX2009009442A (es) 2009-09-14
WO2008116916A1 (en) 2008-10-02
CN101646452A (zh) 2010-02-10
CN101652079A (zh) 2010-02-17
ZA200907731B (en) 2011-04-28
BRPI0809355A2 (pt) 2014-09-02
EP2131859B1 (en) 2016-04-27
AU2008231702A1 (en) 2008-10-02
EP2131680A1 (en) 2009-12-16
AU2008231778A1 (en) 2008-10-02
CA2678994A1 (en) 2008-03-27
CA2682654A1 (en) 2008-10-02
WO2008116892A1 (en) 2008-10-02
EP2131859A1 (en) 2009-12-16
ZA200907538B (en) 2011-04-28
CA2680093A1 (en) 2008-10-02
UA97663C2 (ru) 2012-03-12
RU2009139660A (ru) 2011-05-10
MX2009009931A (es) 2009-09-24
EP2129393A1 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
MX337667B (es) Combinacion simbiotica para mejorar la microbiota intestinal.
RU2008139598A (ru) Синбиотическая смесь
Gibson Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin
Mattila-Sandholm et al. Probiotics: towards demonstrating efficacy
Vernazza et al. Human colonic microbiology and the role of dietary intervention: introduction to prebiotics
RU2010153257A (ru) Пробиотики для улудшения микробиоты пищеварительного тракта
AU2019400658B2 (en) A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
EP2643004B1 (en) Oligosaccharide composition for treating skin diseases
Singh et al. Gut microbiome as a novel cardiovascular therapeutic target
RU2014119844A (ru) Композиция для головного мозга и/или познавательного и/или психомоторного развития
RU2010142003A (ru) Синбиотическая смесь
RU2011104195A (ru) Питательная композиция, содержащая смесь олигосахаридов
RU2014119930A (ru) Композиция, предназначенная для применения в стимулировании здорового костного роста и/или в профилактике, и/или терапии заболеваний кости
UA102830C2 (ru) Профилактика условно-патогенных инфекций у лиц со сниженным иммунитетом
MY146109A (en) Oligosaccharide mixture
RU2014119903A (ru) Композиция для применения при повышении чувствительности к инсулину и/или снижении инсулинорезистентности
CN105283195A (zh) 用于治疗过敏患者的感染的合生素组合物
RU2014119904A (ru) Композиция для применения при стимуляции ангиогенеза в кишечнике, всасывания питательных веществ и переносимости энтерального питания, и/или при профилактике, и/или лечении воспалительных заболеваний кишечника, и/или при выздоровлении после повреждения кишечника и хирургического вмешательства
RU2011106319A (ru) Пробиотики для увелечения секреции iga у младенцев, рожденных посредством кесарева сечения
RU2012117804A (ru) Bifidobacterium longum atcc baa-999 (bl999) и контролирование веса
NZ602249A (en) Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
RU2010126327A (ru) Композиция на основе пробиотических бактерий совместно с пребиотиком и ее применение в предупреждении и/или лечении респираторных патологий и/или инфекций и для улучшения функций кишечника
RU2016129426A (ru) Питательная композиция для снижения метаболического стресса у младенцев
PT2241196E (pt) Suplemento nutricional compreendendo oligossacarídeos e cisteína para o tratamento do vih
AU2019407214B2 (en) A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration